Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study.
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.
Viral and Cellular factors leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.